Significance of Geriatric Assessment for Optimal Treatment of Older Cancer Patients

Odense University Hospital1 site in 1 country114 target enrollmentJanuary 2016

ConditionsCancer

Overview

Phase: Not Applicable
Intervention: Not specified
Conditions: Cancer
Sponsor: Odense University Hospital
Enrollment: 114
Locations: 1
Primary Endpoint: Feasibility of planned oncologic treatment (number of participants, who complete the planned oncologic treatment)
Last Updated: 7 years ago

Overview Investigators Eligibility Criteria Outcomes Sites Similar Trials

Overview

Brief Summary

In a randomized controlled trial, the investigators wish to investigate, if oncologic treatment decision based on G8 screening followed by geriatric assessment and subsequent MDT, if needed, in older frail patients with gynaecologic and urologic cancer is superior to standard assessment (PS and clinical assessment) in oncologic treatment decision.

Registry

clinicaltrials.gov

Start Date

January 2016

End Date

December 2019

Last Updated

7 years ago

Study Type

Interventional

Study Design

Parallel

Sex

All

Investigators

Sponsor

Odense University Hospital

Responsible Party

Principal Investigator

Sambavy Nadaraja

MD, PhD student

Odense University Hospital

Eligibility Criteria

Inclusion Criteria

•Histologically verified gynaecologic cancer (ovarian, uterine, or cervical cancer) or urologic cancer (prostate, bladder, or kidney cancer).
•Suited for first line medical oncologic treatment with chemotherapy and/or targeted therapy.
•Age ≥ 70 years.
•Understands, speaks, and writes Danish.
•Signed informed consent.

Exclusion Criteria

•Previous cancer diagnosis except for carcinoma in situ of the cervix or skin cancer other than malignant melanoma.
•Previous chemotherapy and/or targeted therapy for current cancer diagnosis.
•Previous radiation therapy or concomitant radiotherapy for current cancer diagnosis.
•Surgery within the last 4 weeks.